There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K39/395
Jump to navigation
Jump to search
Subcategories
This category has the following 7 subcategories, out of 7 total.
A
C
J
Pages in category "A61K39/395"
The following 50 pages are in this category, out of 50 total.
1
- 17415589. Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 17784145. COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERS simplified abstract (The Regents of the University of California)
- 18193062. CANCER TREATMENT COMBINATIONS simplified abstract (The Regents of the University of California)
- 18234229. METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18250727. SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18271926. COMBINATION THERAPEUTICS FOR TREATMENT OF PROLIFERATIVE DISORDERS simplified abstract (GEORGIA TECH RESEARCH CORPORATION)
- 18364185. ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF simplified abstract (Genentech, Inc.)
- 18420510. ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE simplified abstract (GENENTECH, INC.)
- 18420955. METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18517327. BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF USE simplified abstract (Genentech, Inc.)
- 18561838. COMPOSITIONS AND METHODS FOR TREATING CANCER simplified abstract (The Regents of the University of Michigan)
- 18596375. CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR simplified abstract (The Regents of the University of California)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (The Trustees of the University of Pennsylvania)
- 18648209. PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES simplified abstract (Genentech, Inc.)
- 18648653. DUAL SPECIFIC ANTIBODIES simplified abstract (GENENTECH, INC.)
- 18656957. HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION simplified abstract (Hoffmann-La Roche Inc.)
- 18659241. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR simplified abstract (GENENTECH, INC.)
- 18680910. ANTI-NPR1 ANTIBODIES AND USES THEREOF simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18708825. COMBINATION THERAPY FOR TREATING LUNG CANCER (Novartis AG)
- 18728163. BACTERIAL COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISEASES (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18737807. COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE (The Board of Trustees of the Leland Stanford Junior University)
- 18742449. TREATMENT OF CANCER USING A HLA-A2/MAGE-A4 X CD3 BISPECIFIC ANTIBODY AND A 4-1BB (CD137) AGONIST simplified abstract (Hoffmann-La Roche Inc.)
- 18757848. PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMULATION (Regeneron Pharmaceuticals, Inc.)
- 18812424. METHODS OF ISOLATING ALLERGEN-SPECIFIC ANTIBODIES FROM HUMANS AND USES THEREOF (The Board of Trustees of the Leland Stanford Junior University)
- 18883719. COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS (The Johns Hopkins University)
- 18956269. METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES (Genentech, Inc.)
2
- 20240010707. De-immunized Factor VIII Molecule and Pharmaceutical Compositions Comprising the Same simplified abstract (Biotest AG)
- 20240016787. METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES simplified abstract (RDiscovery, LLC)
- 20240043503. COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY simplified abstract (ADMA BIOMANUFACTURING, LLC)
A
B
- Biotechnology patent applications on 7th Mar 2025
- Biotechnology patent applications on March 6th, 2025
- Biotechnology patent applications on May 30th, 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on February 8th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on March 7th, 2024
- Blockchain patent applications on May 16th, 2024
T
- The regents of the university of california (20240245770). COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERS simplified abstract
- The regents of the university of california (20250064871). BACTERIAL COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISEASES
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- The Regents of the University of California patent applications on July 25th, 2024
